Evogene Ltd (NASDAQ:EVGN) price on Friday, June 13, fall -9.21% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.38.
A look at the stock’s price movement, the close in the last trading session was $1.52. Turning to its 52-week performance, $7.19 and $0.95 were the 52-week high and 52-week low respectively. Overall, EVGN moved 13.11% over the past month.
Evogene Ltd’s market cap currently stands at around $9.21 million, with investors looking forward to this quarter’s earnings report slated for in July.
7 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 5 recommend EVGN as a Buy and 1 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
EVGN’s current price about 8.25% and 16.60% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 52.34, while 7-day volatility ratio is 43.19% and 17.56% in the 30-day chart. Further, Evogene Ltd (EVGN) has a beta value of 1.58, and an average true range (ATR) of 0.19. Analysts have given the company’s stock an average 52-week price target of $3.5, forecast between a low of $3.5 and high of $3.5. Looking at the price targets, the low is -153.62% off current price level while to achieve the yearly target high, price needs to move -153.62%. Nonetheless, investors will most likely welcome a -153.62% jump to $3.5 which is the analysts’ median price.
If we refocus on Evogene Ltd (NASDAQ:EVGN), historical trading data shows that trading volumes averaged 2.05 million over the past 3 months. The company’s latest data on shares outstanding shows there are 6.67 million shares.
The 1.56% of Evogene Ltd’s shares are in the hands of company insiders while institutional holders own 7.62% of the company’s shares. Current price change has pushed the stock -26.20% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the EVGN stock continues to rise going into the next quarter.
